Who Owns Eloxx Pharmaceuticals Stock?
NASDAQ: ELOXHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
Market open · Delayed 15 min · as of Oct 9, 2:37 PM ET
Ownership breakdown
- Held by institutions
- 73.76%
- Held by insiders
- 19.07%
- Institutional holders
- 25
- Institutions 73.8%
- Insiders 19.1%
- Public and other 7.2%
Who owns Eloxx Pharmaceuticals stock?
Institutional investors own about 73.8% of Eloxx Pharmaceuticals's shares, spread across 25 institutions that file 13F reports. That level of institutional ownership is high, typical of large, widely followed companies. Insiders, including executives, directors and large founding shareholders, hold 19.07% of ELOX.
The largest institutional holders are Aberdeen Group plc (12.73%), Siren, L.L.C. (12.73%) and EcoR1 Capital, LLC (12.73%). Together, the top 10 institutions control 79.5% of shares outstanding. In their latest filings, 10 of the top 10 institutions increased their ELOX positions and 0 reduced them.
Summary generated from market data by MetaCap's automated system. Methodology
Top institutional holders of ELOX
| Institution | Shares | % Held | Change |
|---|---|---|---|
| Aberdeen Group plc | 400.00K | 12.73% | +100.0% |
| Siren, L.L.C. | 400.00K | 12.73% | +100.0% |
| EcoR1 Capital, LLC | 400.00K | 12.73% | +100.0% |
| Nantahala Capital Management, LLC | 400.00K | 12.73% | +100.0% |
| Samsara BioCapital, LLC | 400.00K | 12.73% | +100.0% |
| Stonepine Capital Management, LLC | 397.16K | 12.63% | +100.0% |
| Vanguard Capital Management LLC | 78.68K | 2.50% | +100.0% |
| Vanguard Fiduciary Trust Co | 10.60K | 0.34% | +100.0% |
| Seven Grand Managers, LLC | 10.00K | 0.32% | +100.0% |
| Morgan Stanley | 1.54K | 0.05% | +100.0% |
% held is the share of total shares outstanding. Change is the percentage change in the position since the holder's previous 13F filing.
Top mutual fund and ETF holders of ELOX
| Fund | Shares | % Held |
|---|---|---|
| abrdn Healthcare Investors | 605.50K | 19.26% |
| abrdn Life Sciences Investors | 294.50K | 9.37% |
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 57.48K | 1.83% |
| VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund | 19.29K | 0.61% |
| Fidelity Concord Street Trust-Fidelity Nasdaq Composite Index Fund | 2.29K | 0.07% |
| VANGUARD VALLEY FORGE FUNDS-Vanguard Balanced Index Fund | 1.04K | 0.03% |
| VANGUARD Inst. INDEX Fd.S-Vanguard Inst. Total Stock Market Index Fd. | 877 | 0.03% |
Frequently asked questions
Who is the largest shareholder of Eloxx Pharmaceuticals?
Aberdeen Group plc is the largest institutional shareholder of ELOX, owning 12.73% of shares outstanding (400.00K shares) as of its latest 13F filing.
What percentage of Eloxx Pharmaceuticals is owned by institutions?
Institutions own about 73.8% of ELOX shares and 91.1% of the public float.
How much of Eloxx Pharmaceuticals do insiders own?
Insiders, such as officers and directors, own about 19.07% of ELOX shares outstanding.
Where does institutional ownership data come from?
Investment managers with more than $100 million in US equities must file Form 13F with the SEC within 45 days of each quarter-end. Holdings are therefore up to about 4.5 months old when published.